Katherine J. Adams
Immunocore (United Kingdom)(GB)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Immune Cell Function and Interaction
Most-Cited Works
- → Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells(2013)661 cited
- → Monoclonal TCR-redirected tumor cell killing(2012)313 cited
- → Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition(2010)131 cited
- → Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors(2012)96 cited
- → An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules(2018)82 cited
- → Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β(2021)18 cited
- Monoclonal TCR-redirected tumor cell killing. Nat Med(2012)
- → High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation(2010)9 cited
- → Abstract 3525: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma(2012)4 cited
- → 045 Melanocyte-targeted Bispecific PD-1 Agonists as Localized Immune Suppressants against Vitiligo(2022)2 cited